Fletcher S - Search Results

1

Stargardt disease and progress in therapeutic strategies.

Huang D, Heath Jeffery RC, Aung-Htut MT, McLenachan S, Fletcher S, Wilton SD, Chen FK. Huang D, et al. Among authors: fletcher s. Ophthalmic Genet. 2022 Feb;43(1):1-26. doi: 10.1080/13816810.2021.1966053. Epub 2021 Aug 29. Ophthalmic Genet. 2022. PMID: 34455905 Review.

2

Snapback SSCP analysis: engineered conformation changes for the rapid typing of known mutations.

Wilton SD, Honeyman K, Fletcher S, Laing NG. Wilton SD, et al. Among authors: fletcher s. Hum Mutat. 1998;11(3):252-8. doi: 10.1002/(SICI)1098-1004(1998)11:3<252::AID-HUMU11>3.0.CO;2-Y. Hum Mutat. 1998. PMID: 9521428

3

Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele.

Honeyman K, Carville KS, Howell JM, Fletcher S, Wilton SD. Honeyman K, et al. Among authors: fletcher s. Am J Vet Res. 1999 Jun;60(6):734-7. Am J Vet Res. 1999. PMID: 10376903

4

Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.

Wilton SD, Lloyd F, Carville K, Fletcher S, Honeyman K, Agrawal S, Kole R. Wilton SD, et al. Among authors: fletcher s. Neuromuscul Disord. 1999 Jul;9(5):330-8. doi: 10.1016/s0960-8966(99)00010-3. Neuromuscul Disord. 1999. PMID: 10407856

5

Gene therapy and molecular approaches to the treatment of hereditary muscular disorders.

Fletcher S, Wilton SD, Howell JM. Fletcher S, et al. Curr Opin Neurol. 2000 Oct;13(5):553-60. doi: 10.1097/00019052-200010000-00008. Curr Opin Neurol. 2000. PMID: 11073362 Review.

6

Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.

Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, Morgan JE, Partridge TA, Wilton SD. Mann CJ, et al. Among authors: fletcher s. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):42-7. doi: 10.1073/pnas.98.1.42. Proc Natl Acad Sci U S A. 2001. PMID: 11120883 Free PMC article.

7

Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy.

Fletcher S, Ly T, Duff RM, McC Howell J, Wilton SD. Fletcher S, et al. Neuromuscul Disord. 2001 Apr;11(3):239-43. doi: 10.1016/s0960-8966(00)00187-5. Neuromuscul Disord. 2001. PMID: 11297938

8

Evaluation of a short interspersed nucleotide element in the 3' untranslated region of the defective dystrophin gene of dogs with muscular dystrophy.

Fletcher S, Carville KS, Howell JM, Mann CJ, Wilton SD. Fletcher S, et al. Am J Vet Res. 2001 Dec;62(12):1964-8. doi: 10.2460/ajvr.2001.62.1964. Am J Vet Res. 2001. PMID: 11763189 Free article.

9

Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?

Wilton SD, Fletcher S. Wilton SD, et al. Among authors: fletcher s. Neuromuscul Disord. 2005 Jun;15(6):399-402. doi: 10.1016/j.nmd.2005.03.003. Epub 2005 Apr 18. Neuromuscul Disord. 2005. PMID: 15907285 Review. No abstract available.

10

RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.

Wilton SD, Fletcher S. Wilton SD, et al. Among authors: fletcher s. Curr Gene Ther. 2005 Oct;5(5):467-83. doi: 10.2174/156652305774329249. Curr Gene Ther. 2005. PMID: 16250888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,484 results

Search Page